← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
101	101 Estrella Immunopharma ESLA $23.3M	7	+4	+133%	$143K
102	102 Genenta Science GNTA $32.3M	4	+1	+33%	$3.67M
103	103 NewcelX Ltd NCEL $16.5M	4	-2	-33%	$3.44M
104	PTE 104 DELISTED PolarityTE, Inc. Common Stock PTE	4	+2	+100%	$4
105	TCBP 105 DELISTED TC BioPharm (Holdings) plc American Depositary Shares TCBP	3	-8	-73%	$244K
106	106 CytoMed Therapeutics GDTC $10.4M	2	0	0%	$21.5K
107	BLCM 107 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	1	+1	–	–
108	DBTX 108 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	1	0	0%	$36.4K
109	SCPS 109 DELISTED Scopus BioPharma Inc. Common Stock SCPS	1	+1	–	–
110	CYAD 110 DELISTED Celyad Oncology SA American Depositary Shares CYAD	0	-1	-100%	$0
111	SGTX 111 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	0	-1	-100%	$0
112	SQZ 112 DELISTED SQZ Biotechnologies Company SQZ	0	-5	-100%	$0
113	AGTC 113 DELISTED Applied Genetic Technologies Corporation AGTC	–	–	–	–
114	AKUS 114 DELISTED Akouos Inc AKUS	–	–	–	–
115	115 Artiva Biotherapeutics ARTV $296M	–	–	–	–
116	ATNX 116 DELISTED Athenex, Inc. Common Stock ATNX	–	–	–	–
117	117 FibroBiologics FBLG $7.08M	–	–	–	–
118	118 Fractyl Health GUTS $55.2M	–	–	–	–
119	ISEE 119 DELISTED IVERIC bio, Inc. Common Stock ISEE	–	–	–	–
120	KRBP 120 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	–	–	–	–
121	121 Kyverna Therapeutics KYTX $369M	–	–	–	–
122	LOGC 122 DELISTED LogicBio Therapeutics, Inc. Common Stock LOGC	–	–	–	–
123	123 Metagenomi Therapeutics MGX $31.9M	–	–	–	–
124	OBX 124 Obsidian Therapeutics OBX $754M	–	–	–	–
125	ONCS 125 DELISTED OncoSec Medical Incorporated ONCS	–	–	–	–